These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6594925)

  • 1. Sequential combination of methotrexate and vindesine in previously treated children with acute leukemia. A phase I-II study.
    Miller LP; Hancock C; Miller DR; Chello PL; Sirotnak FM; Tan CT
    Am J Clin Oncol; 1984 Oct; 7(5):465-70. PubMed ID: 6594925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vindesine in the treatment of refractory hematologic malignancies: a phase II study.
    Mandelli F; Amadori S; Giona F; Antonietta M; Spiriti A; Pastore S; Meloni G; Paolucci G
    Leuk Res; 1982; 6(5):649-52. PubMed ID: 7154707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of vindesine in patients with acute leukemia.
    Sklaroff RB; Arlin Z; Young CW
    Cancer Treat Rep; 1979; 63(11-12):2063-5. PubMed ID: 294307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phase II study of vindesine in hematological malignancies].
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2509-15. PubMed ID: 6580841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vindesine: a phase II study in childhood malignancies-a report for cancer and leukemia group B.
    Ettinger LJ; Brecher M; Coleman M; Smithson WA; Patterson R; Russell EC; Necheles T; Jones B; Ohnuma T
    Med Pediatr Oncol; 1982; 10(1):35-43. PubMed ID: 7038420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Administration of vindesine sulfate for the treatment of malignant hematological tumors].
    Ueda T; Masaoka T; Shibata H; Kubota Y; Saigo K; Kusakabe H; Takubo T; Nakamura H; Yoshitake J; Ishigami S
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):306-15. PubMed ID: 6764103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A presumed transient hemolytic reaction following vinca alkaloids administration in patients with hematological malignancies].
    Iwata N; Wakamatsu E; Oike S; Umegae S; Omine M; Maekawa T; Tsuchiya J
    Rinsho Ketsueki; 1984 May; 25(5):649-54. PubMed ID: 6590896
    [No Abstract]   [Full Text] [Related]  

  • 8. A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. A Pediatric Oncology Group study.
    Vats T; Buchanan G; Mehta P; Ragab A; Hvizdale E; Nitschke R; Link M; Beardsley GP; Maybee D; Krischer J
    Invest New Drugs; 1992 Aug; 10(3):231-4. PubMed ID: 1428733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group.
    Krivit W; Anderson J; Chilcote R; Pyesmany A; Chard R; Hammond D
    Am J Pediatr Hematol Oncol; 1980; 2(3):217-21. PubMed ID: 7001942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the therapeutic response of patients with childhood acute lymphoblastic leukemia in relapse to vindesine versus vincristine in combination with prednisone and L-asparaginase: a phase III trial.
    Anderson J; Krivit W; Chilcote R; Pyesmany A; Chard R; Hammond D
    Cancer Treat Rep; 1981; 65(11-12):1015-9. PubMed ID: 6945911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Continuous 5-day vindesine in the treatment of leukemias and lymphomas (author's transl)].
    Maraninchi D; Gastaut JA; Tubiana N; Carcassonne Y
    Bull Cancer; 1981; 68(4):338-42. PubMed ID: 6947833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An initial report of a phase-III trial comparing vindesine and vincristine for acute lymphocytic leukemia of childhood.
    Krivit W; Chilcote R; Pyesmany A; Anderson J; Hammond D
    Cancer Chemother Pharmacol; 1979; 2(4):267-70. PubMed ID: 287570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of refractory acute lymphoblastic leukemia with teniposide and cytarabine.
    Kamen BA; Casper J; Lauer S; Camitta BM; Holcenberg JS
    Cancer Treat Rep; 1986 Jul; 70(7):935-6. PubMed ID: 3459577
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phase II study of Vindesine in patients with hematological malignancy].
    Sampi K; Honda T; Hayashi Y; Hattori M
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1536-7. PubMed ID: 6347082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vindesine and prednisone for remission induction in children with acute lymphocytic leukemia.
    Vats TS; Mehta P; Trueworthy RC; Smith SD; Klopovich P
    Cancer; 1981 Jun; 47(12):2789-92. PubMed ID: 6942907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)].
    Marthé G; Misset JL; de Vassal F; Hayat M; Gouveia J; Machover D; Belpomme D; Schwarzenberg L; Ribaud P; Pico JL; Musset M; Jasmin C; de Luca L
    Nouv Presse Med; 1978 Feb; 7(7):525-8. PubMed ID: 273888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I evaluation of vindesine in children: a Southwest Oncology Group pilot study.
    Komp D; Vats T; Shepherd DA; Vietti T; Hoogstraten B; Haas CD
    Med Pediatr Oncol; 1980; 8(3):243-50. PubMed ID: 7193278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute lymphoblastic leukemia in adults with combination chemotherapy incorporating vindesine and prednisolone.
    Saito Y; Uzuka Y
    Tohoku J Exp Med; 1983 Apr; 139(4):421-2. PubMed ID: 6575488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse.
    Garay G; Milone J; Dibar E; Pavlovsky S; Kvicala R; Sackmann Muriel F; Montres Varela D; Eppinger-Helft M
    Cancer Chemother Pharmacol; 1983; 10(3):224-6. PubMed ID: 6345018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic-guided trial of sequential methotrexate and thioguanine in children with advanced malignancies.
    Tan CT; Wollner N; Trippett T; Goker E; Tong WP; Kheradpour A; Meyers PA; VanSyckle KM; Guarino L; Elisseyeff Y
    J Clin Oncol; 1994 Sep; 12(9):1955-62. PubMed ID: 7521908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.